Sterling Pharma Solutions, a UK-based CDMO, has entered a toll processing agreement with TPI Enterprises to manufacture Codeine Phosphate (CPO) for sale in the UK.   As part of the agreement, TPI Enterprises, one of three licensed poppy processors in Australia, will produce the narcotic raw material (NRM) at its site in Victoria, and Sterling will manufacture the CPO at its Dudley site near Newcastle, UK.   This agreement is part of TPI’s plan to expand its presence in the UK market.   Kev...